Labshake search
Citations for R&D Systems :
401 - 450 of 5224 citations for Human Anti NT5E Recombinant Antibody clone Hu101 28 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Cancer Biology 2024Quote: ... and 50 ng/mL recombinant human M-CSF (R&D Systems 216-MC). M1 macrophage attachment medium was prepared using DMEM supplemented with 10% heat-inactivated FBS ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human IFN-γ (2 ng/ml) (285-IF-100, R&D Systems), recombinant human TNFα (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10ng/mL of recombinant human β-NGF (R&D Systems, 256-GF) in HBSS without calcium and magnesium (Thermo Scientific ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human lymphotoxin α1/ β2 (rhLTα1/β2) (R&D Systems, Cat# 8884-LY) or recombinant human IFNγ (PeproTech Cat# 300-02 ...
-
bioRxiv - Synthetic Biology 2024Quote: ... 10 ng mL-1 recombinant human BDNF protein (R&D Systems, 248-BDB), and 10 ng mL-1 recombinant human GDNF protein (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL recombinant human M-CSF (R&D Systems, 216-MC). M1 macrophage culture medium was prepared using DMEM supplemented with 10% heat- inactivated FBS ...
-
bioRxiv - Developmental Biology 2024Quote: ... 80 ng/mL recombinant human R-spondin-1 (R&D Systems, 4645-RS), 100 ng/mL recombinant human FGF-2 ...
-
bioRxiv - Immunology 2022Quote: Cell surface staining for the anti-HER2 BCR was performed with Recombinant Human ErbB2/Her2 Fc Chimera Protein (R&D Systems) and APC anti-His Tag antibody (Biolegend ...
-
bioRxiv - Cell Biology 2020Quote: ... The beads were removed by centrifugation and the phosphorylated GST-NEPHRIN and GST-NEPH1 were mixed with recombinant purified active SHP-2 (Recombinant Human SHP-2; Cat. No.: 1894-SH; R&D Systems) in the presence of phosphatase buffer (10mM HEPES ...
-
bioRxiv - Neuroscience 2022Quote: ... and stained with anti-tubulin βIII antibody (R&D systems, Tuj1 clone, 1:1000). Extent of axonal repulsion was measured by the ratio between the lengths of the proximal axons (i.e. ...
-
bioRxiv - Microbiology 2021Quote: ... an anti-gC1qR antibody (clone 74.5.2) or control mouse IgG (R&D systems; #MAB002) for 1 h ...
-
bioRxiv - Bioengineering 2024Quote: ... 50 ng/μl of purified anti-mouse CD63 antibody (Clone 446703, R&D Systems) or purified anti-mouse FN antibody (#IRBAMSFBNGF ...
-
bioRxiv - Microbiology 2020Quote: ... A polyclonal antibody against human ACE2 and anti-IDE polyclonal antibody were purchased from R&D Systems (catalog No ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Pathology 2023Quote: The ROSAKIT WT human cell line (RRID:CVCL_5G49) was cultured in the presence of recombinant human SCF (80 ng/mL, R&D Systems), as described previously (23) ...
-
bioRxiv - Molecular Biology 2021Quote: ... Antibodies used were anti-human ESRRB /NR3B2 (R&D systems; PP-H6705-00), anti-GAPDH (Abcam ...
-
bioRxiv - Immunology 2022Quote: ... and incubated with anti-human/mouse CD117 (c-kit) antibody (R&D Systems), anti-integrinβ7 antibody (FIB504 ...
-
bioRxiv - Immunology 2023Quote: ... Anti-human IL-1β antibody (AF-201-NA) was from R&D Systems. Anti-murine IL-1β antibody (5129-100 ...
-
bioRxiv - Cell Biology 2024Quote: The following primary antibodies were used: human anti-DSG2 (MAB947, R&D systems), rabbit anti-DPC antibody (A303-356A ...
-
bioRxiv - Biochemistry 2021Quote: Human anti-SP IgG or ACE-2 Fc was mixed with recombinant SARS-CoV-2 spike RBD His tag (R&D Systems) or recombinant SARS-CoV-2 spike RBD (N501Y)-His tag (Sino Biological ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Cell Biology 2020Quote: ... were incubated with 100μg/ml recombinant human Wnt10b protein (0.1mg/ml;R&D Systems) at 37°C for 30 minutes ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...
-
bioRxiv - Bioengineering 2021Quote: ... 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q) with recombinant human IL-2 protein from R&D Systems (#202-IL). After a 24 hr culture out of thaw the PBMCs were activated with ImmunoCult™ human CD3/CD28 T cell activator reagent from STEMCELL Technologies (#10971 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Immunology 2022Quote: ... supplemented with 30 U/mL recombinant human IL-2 (R&D Systems #202-IL), and 55 μM beta- mercaptoethanol (Thermo # 21985023) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Physiology 2020Quote: ... at concentrations between 1-100 nM or recombinant human sclerostin (rhSCL) (R&D Systems) at concentrations between 1-50 ng/ml [28 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Recombinant human decorin protein (#143-DE-100) was purchased from R&D Systems (USA). Anti-decorin (#HPA064736) ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Cell Biology 2021Quote: ... Recombinant Human SHH Protein for SHH pathway activation was purchased from R&D systems.
-
bioRxiv - Immunology 2022Quote: ... in absence or presence of APRIL (Recombinant Human APRIL/TNFSF13 Protein, R&D systems) at 50 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... the samples were treated with human recombinant LOXL3 (RhLOXL3, R&D systems, 6069-AO) or LOXL2 (RhLOXL2 ...